Individuals Coming Off Anti-Obesity Medications Put On Pounds Far More Rapidly Than Dieters

Fresh analysis indicates that people who come off popular GLP-1 drugs like Wegovy and Mounjaro may regain lost weight far faster than those who halt traditional diet and exercise regimens.

Findings released in a major medical journal demonstrates that while overweight people frequently drop a large proportion of their total mass while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"Individuals using these treatments need to be aware of the risk of fast rebound weight gain when the therapy concludes," stated lead investigator Dr. Susan Jebb.

Such speed of regain implies a return to pre-treatment weight within about a year and a half.

Analyzing Therapies

The research, which looked at dozens of trials involving over 9,000 of patients, contrasted the results of these new drugs with older methods.

The team note that people who lose weight through lifestyle changes alone generally have a more gradual creep back—approximately 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Experts believe the way of the jabs is key to understanding the heightened rebound.

GLP-1 drugs imitate a natural hormone called GLP-1, which controls appetite.

"Artificially providing GLP-1 levels far above than the body's typical production may cause the body to generate a reduced amount of its endogenous GLP-1, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this hormone supplement leads to appetite is uncontrolled, making overeating a significant risk."

An Ongoing Disease?

Health authorities advise the injections for people with obesity-related health risks, alongside recommended diet and exercise modifications.

Professionals say that, considering the high risk of weight regain, the treatment might need to be long-term.

This opinion is reinforced by drug manufacturers, who state that the findings "emphasize the long-term nature of excess weight," comparing it to managing diseases like diabetes.

User Testimonies

Individuals who have stopped the jabs explain a intense return of cravings.

"I experienced a switch flipping and I was suddenly starving," described an individual.

The struggle is compounded if patients have not developed permanent dietary or behavioural changes during treatment.

Significant Adoption

Figures indicate that a significant number of adults in the UK have used these injections in the past year, with interest continuing to grow.

• Use is higher among females compared to males.
• The 40s and 50s demographic shows the highest level of interest.
• Many access the drugs through private prescriptions rather than public health services.

Finally, researchers emphasize that while the jabs are effective agents for weight loss, they are not a permanent fix and maintained weight loss relies on ongoing lifestyle support.